Strategic Growth G&L Scientific has recently expanded through the majority acquisition of SmartStep Consulting, signaling an active growth trajectory and potential fit for cross-sell of market access, regulatory, and strategic advisory services to SmartStep's client base.

Integrated Platform Positioned as a unified source of end-to-end product development and market access solutions, there are opportunities to upsell additional regulatory submissions, agency interactions, quality/compliance, and business transformation services to existing and new clients.

Health Sector Focus With a health and human services focus and a patient-outcomes orientation, target prospects in biopharma and biotech seeking integrated development, regulatory, and market access capabilities to accelerate time-to-market.

Mid-Market Size Operating with 51-200 employees and revenue in the $10M–$25M range, G&L Scientific sits in a mid-market segment ripe for recurring services, partnerships, and value-based pricing opportunities with mid-sized pharma and consulting firms.

Tech Enablement Adoption of tools like Salesforce, SAP, Microsoft 365, and AI assistants indicates readiness for efficiency improvements, data-driven regulatory submissions, and scalable client delivery—offer related optimization, CRM/ERP integration, and training services to strengthen delivery and expand footprints.